SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ning Luo, Weiwei Qi, Can Zhuang, Wei Di, Yonggang Lu, Zongqing Huang, Yunguang Sun, Aiwu Zhang, Xiaoliang Huang, Yuqian Tao, Yingting Zhu, Aidong Li, Zhonghua Jiang, Mark W. Massing, Yannan Fang, A Satisfaction Survey of Current Medicines Used for Migraine Therapy in China: Is Chinese Patent Medicine Effective Compared with Western Medicine for the Acute Treatment of Migraine?, Pain Medicine, 2014, 15, 2
  2. 2
    Rebecca Erwin Wells, Rebecca Burch, Randall H. Paulsen, Peter M. Wayne, Timothy T. Houle, Elizabeth Loder, Meditation for Migraines: A Pilot Randomized Controlled Trial, Headache: The Journal of Head and Face Pain, 2014, 54, 9
  3. 3
    Mia Euler, Sara Keshani, Katarina Baatz, Bjorn Wettermark, Utilization of triptans in Sweden; analyses of over the counter and prescription sales, Pharmacoepidemiology and Drug Safety, 2014, 23, 11
  4. 4
    Stewart J. Tepper, Susy Chen, Faith Reidenbach, Alan M. Rapoport, Intranasal Zolmitriptan for the Treatment of Acute Migraine, Headache: The Journal of Head and Face Pain, 2013, 53,
  5. 5
    Paul L. Durham, Caleb G. Masterson, Two Mechanisms Involved in Trigeminal CGRP Release: Implications for Migraine Treatment, Headache: The Journal of Head and Face Pain, 2013, 53, 1
  6. 6
    Abraham J. Nagy, Alan M. Rapoport, Update on future headache treatments, Neurological Sciences, 2013, 34, S1, 101

    CrossRef

  7. You have free access to this content7
    Lawrence C. Newman, Why Triptan Treatment Can Fail: Focus on Gastrointestinal Manifestations of Migraine, Headache: The Journal of Head and Face Pain, 2013, 53,
  8. 8
    Carlo Lisotto, Giorgio Zanchin, Optimizing triptan therapy in clinical practice, Clinical Practice, 2012, 9, 3, 329

    CrossRef

  9. 9
    Kathy Erlichson, Julie Waight, Therapeutic applications for subcutaneous triptans in the acute treatment of migraine, Current Medical Research and Opinion, 2012, 28, 7, 1231

    CrossRef

  10. 10
    Timothy R. Smith, Jerome Goldstein, Richard Singer, Neil Pugach, Stephen Silberstein, Mark W. Pierce, Twelve-Month Tolerability and Efficacy Study of NP101, the Sumatriptan Iontophoretic Transdermal System, Headache: The Journal of Head and Face Pain, 2012, 52, 4
  11. 11
    Sheena K. Aurora, Stephen D. Silberstein, Shashidhar H. Kori, Stewart J. Tepper, Scott W. Borland, Min Wang, David W. Dodick, MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine, Headache: The Journal of Head and Face Pain, 2011, 51, 4
  12. 12
    Kerstin Hedborg, Carin Muhr, Multimodal behavioral treatment of migraine: An Internet-administered, randomized, controlled trial, Upsala Journal of Medical Sciences, 2011, 116, 3, 169

    CrossRef

  13. 13
    Roger K. Cady, Sheena K. Aurora, Jan L. Brandes, John F. Rothrock, Judith A. Myers, Anthony W. Fox, Stephen J. Farr, Satisfaction With and Confidence in Needle-Free Subcutaneous Sumatriptan in Patients Currently Treated with Triptans, Headache: The Journal of Head and Face Pain, 2011, 51, 8
  14. 14
    Marcelo E. Bigal, Tolerance to Headache Medications, Headache: The Journal of Head and Face Pain, 2011, 51, 8
  15. 15
    Anna Ferrari, Ilaria Tiraferri, Laura Neri, Emilio Sternieri, Why pharmacokinetic differences among oral triptans have little clinical importance: a comment, The Journal of Headache and Pain, 2011, 12, 1, 5

    CrossRef

  16. 16
    E. Anne MacGregor, Stephen P. Pawsey, John C. Campbell, Xiaojun Hu, Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies, Gender Medicine, 2010, 7, 2, 88

    CrossRef

  17. 17
    Alexander Z. Tzabazis, Sharon H. Niv, Neil A. Manering, Mikhail Klyukinov, Jason M. Cuellar, Anish Bhatnagar, David C. Yeomans, Trigeminal antihyperalgesic effect of intranasal carbon dioxide, Life Sciences, 2010, 87, 1-2, 36

    CrossRef

  18. 18
    KA Maubach, RJ Davis, DE Clark, G Fenton, PM Lockey, KL Clark, AW Oxford, RM Hagan, C Routledge, RA Coleman, BGC20-1531, a novel, potent and selective prostanoid EP4 receptor antagonist: a putative new treatment for migraine headache, British Journal of Pharmacology, 2009, 156, 2
  19. 19
    Lutz Pageler, Hans-Christoph Diener, Volker Pfaffenrath, Hubertus Peil, Bernhard Aicher, Clinical Relevance of Efficacy Endpoints in OTC Headache Trials, Headache: The Journal of Head and Face Pain, 2009, 49, 5
  20. 20
    Marcelo E. Bigal, Tony W. Ho, Is there an inherent limit to acute migraine treatment efficacy?, The Journal of Headache and Pain, 2009, 10, 6, 393

    CrossRef

  21. 21
    Pedro A. Kowacs, Elcio J. Piovesan, Stewart J. Tepper, Rejection and Acceptance of Possible Side Effects of Migraine Prophylactic Drugs, Headache: The Journal of Head and Face Pain, 2009, 49, 7
  22. 22
    A Panconesi, E Pavone, M Franchini, N Mennuti, ML Bartolozzi, L Guidi, R Banfi, Triptans: low utilization and high turnover in the general population, Cephalalgia, 2009, 29, 12
  23. 23
    Catalina Cleves, Stewart J Tepper, Sumatriptan/naproxen sodium combination for the treatment of migraine, Expert Review of Neurotherapeutics, 2008, 8, 9, 1289

    CrossRef

  24. You have free access to this content24
    David B. Matchar, Linda Harpole, Gregory P. Samsa, Annette Jurgelski, Richard B. Lipton, Stephen D. Silberstein, William Young, Shashidhar Kori, Andrew Blumenfeld, The Headache Management Trial: A Randomized Study of Coordinated Care, Headache: The Journal of Head and Face Pain, 2008, 48, 9
  25. 25
    Alessandro Panconesi, Eleonora Pavone, Franca Vacca, Monica Vaiani, Roberto Banfi, Triptans in the Italian population: a drug utilization study and a literature review, The Journal of Headache and Pain, 2008, 9, 2, 71

    CrossRef

  26. 26
    Andrew Charles, Kevin C Brennan, Sumatriptan–naproxen combination for acute migraine, Nature Clinical Practice Neurology, 2007, 3, 11, 604

    CrossRef